Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043300 · ClinicalTrials.gov registry record
A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
A clinical trial of Dysbiosis, sponsored by Emory University.
- Completed
- Registry status
- 10
- Enrollment target
- 2
- Study locations
NCT03043300 is a study of Dysbiosis that has completed, run by Emory University. The registered enrollment target is 10 participants, below the 114-participant average among 13 other Dysbiosis trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03043300, a study of Dysbiosis, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This prospective, observational pilot study is designed to assess feasibility, refine the target population, and quickly test qualitative and quantitative changes in the microbiome after short-term travel to South or Southeast Asia, regions where rates of travelers' diarrhea and intestinal colonization with antimicrobial resistant bacteria are highest. To measure the diversity change of the intestinal microbiota, participants will complete a questionnaire and provide a stool specimen at three different time points: prior to traveling, two weeks after returning from traveling, and 14 weeks after returning from traveling.
Conditions Studied
Interventions
- OTHER Screening Criteria Review
- OTHER Pre-Travel Questionnaire
- OTHER Pre-Travel Stool Specimen Collection
- OTHER Short-Term Post-Travel Questionnaire
- OTHER Short-Term Post-Travel Stool Specimen Collection
Study Locations (2)
Georgia
- Emory Univeristy Hospital Midtown, TravelWell Center - Atlanta
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-11-07 |
| Est. Completion | 2018-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03043300
The ClinicalTrials.gov registry entry for NCT03043300 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 114-participant average among 13 other Dysbiosis trials with a reported enrollment target (91% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dysbiosis appearing as the primary indexed condition, and to 5 interventions - of which Screening Criteria Review is the first listed.
NCT03043300 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03043300 about?
NCT03043300 is a clinical study titled "A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US". This prospective, observational pilot study is designed to assess feasibility, refine the target population, and quickly test qualitative and quantitative changes in the microbiome after short-term travel to South or Southeast Asia, regions where rates of travelers' diarrhea and intestinal colonizat...
What is the current status of trial NCT03043300?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-11-07. Estimated completion is 2018-12-01.
What conditions does trial NCT03043300 study?
This clinical trial studies the following conditions: Dysbiosis.
What interventions are being tested in trial NCT03043300?
The interventions under investigation include: Screening Criteria Review (OTHER), Pre-Travel Questionnaire (OTHER), Pre-Travel Stool Specimen Collection (OTHER), Short-Term Post-Travel Questionnaire (OTHER), Short-Term Post-Travel Stool Specimen Collection (OTHER).
Who is sponsoring clinical trial NCT03043300?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03043300 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysbiosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Peanut Butter on Gut and Metabolic Health
RECRUITING · NA
-
Personalized GI Motility Responses to Diet
RECRUITING · NA
-
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
RECRUITING · NA
-
A Study of Healthy Microbiome, Healthy Mind
RECRUITING · NA
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Effect of Watermelon on Gut and Cardiometabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.